Bayesian extensions of the Tobit model for analyzing measures of health status

被引:32
作者
Austin, PC
机构
[1] Inst Clin Evaluat Sci, N York, ON M4N 3M5, Canada
[2] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada
关键词
Tobit model; Health Utilities Index; health status; ceiling effect; Bayesian statistics; Bayes factors;
D O I
10.1177/02729890222063035
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Self-reported health status is often measured using utility indices that provide a score intended to summarize an individual's health. Measurements of health status can be subject to a ceiling effect. Frequently, researchers want to examine relationships between determinants of health and measures of health status. In this article, Bayesian extensions of the classical Tobit model are used to study the relationship between health status and Predictors of health. The author examined models where the conditional distribution of health status was either normal or lognormal, and allowed for both homoscedasticity and heteroscedasticity. Bayes factors were then used to compare the evidence for a given model against that for a competing model. The author found very strong evidence that the distribution of the Health Utilities Index, conditional on age, gender. income adequacy, and number of chronic conditions, was normal with nonuniform variance, compared to the competing models.
引用
收藏
页码:152 / 162
页数:11
相关论文
共 27 条
[1]  
[Anonymous], MEASURING FUNCTIONIN
[2]   The use of the Tobit model for analyzing measures of health status [J].
Austin, PC ;
Escobar, M ;
Kopec, JA .
QUALITY OF LIFE RESEARCH, 2000, 9 (08) :901-910
[3]  
AUSTIN PC, 2002, IN PRESS VALUE HLTH
[4]   BAYES INFERENCE IN THE TOBIT CENSORED REGRESSION-MODEL [J].
CHIB, S .
JOURNAL OF ECONOMETRICS, 1992, 51 (1-2) :79-99
[5]   Bayesian Tobit modeling of longitudinal ordinal clinical trial compliance data with nonignorable missingness [J].
Cowles, MK ;
Carlin, BP ;
Connett, JE .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1996, 91 (433) :86-98
[6]  
Feeny D., 1996, QUALITY LIFE PHARMAC, P239
[7]   METHODOLOGY FOR MEASURING HEALTH-STATE PREFERENCES .1. MEASUREMENT STRATEGIES [J].
FROBERG, DG ;
KANE, RL .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1989, 42 (04) :345-354
[8]  
Gelman A, 2013, BAYESIAN DATA ANAL, DOI DOI 10.1201/9780429258411
[9]  
Geweke J., 1992, Bayesian Statistics, V4, P169, DOI DOI 10.21034/SR.148
[10]  
Gilks W., 1995, Markov Chain Monte Carlo in Practice, DOI 10.1201/b14835